Pharmacist-led gout treatment for veterans
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether a pharmacist-led program can help veterans with gout better manage their uric acid levels using common medications like allopurinol or febuxostat. If you have had a gout flare in the last 6 months and are already taking or starting a urate-lowering medication, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a US military veteran
- A doctor has told you that you have gout
- You have had at least one gout flare in the last 6 months
- You are prescribed a gout medication like allopurinol or febuxostat (or about to start one)
- You have not seen a rheumatologist in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This trial tests if gradually lowering the dose of the gout medication febuxostat is safe for people whose gout has been well-controlled for at least 5 years. The goal is to see if a lower dose can still keep uric acid levels in a healthy range.
This trial tests a new medicine called tigulixostat against febuxostat, a standard gout treatment, to see which works better at lowering uric acid levels. You may qualify if you have gout with high uric acid and have not had a gout flare in the last month.
This trial tests a new medicine, PRX-115, given through a vein, to see if it lowers uric acid levels in people with gout who haven't had success with standard treatments. Some participants will also take methotrexate, and the results are compared to a placebo (a dummy infusion).
This study tests whether a “tighter” gout treatment plan guided through a smartphone app can reduce gout flare-ups compared with usual care. It may help people whose uric acid levels are still high despite treatment.
This trial tests an experimental drug, SSS11, to see if it is safe and how it affects uric acid levels in people with gout and high uric acid. You may not take other gout medicines during the study.
Hear when a new Gout trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.